| Author (Corporate) | European Commission: DG Health and Consumer Protection |
|---|---|
| Publisher | EC |
| Publication Date | 2006 |
| Content Type | Key Source, Overview |
|
An increasing number of patients in the EU receive treatments based on biological substances donated by others. These include blood, tissues, cells, and whole human organs. Such substances are of high therapeutic value, but they may also carry risks for the recipients, in particular the transmission of communicable diseases. The Community contributes to reducing such risks by adopting legislation on quality and safety of these substances, and by funding projects in this area. |
|
| Source Link | http://ec.europa.eu/comm/health/ph_threats/human_substance/blood_tissues_organs_en.htm |
| Subject Categories | Health |
| Countries / Regions | Europe |
